Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular T-Cell Repertoire Analysis as Source of Prognostic and Predictive Biomarkers for Checkpoint Blockade Immunotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 7, Pages 2378
Publisher
MDPI AG
Online
2020-04-01
DOI
10.3390/ijms21072378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Outcomes in BRAF-Mutated Melanoma Treated with Combined Targeted Therapy or Immune Checkpoint Blockade: Are We Approaching a True Cure?
- (2020) Patrick Schummer et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
- (2020) Jackson G. Egen et al. IMMUNITY
- Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- (2020) Luisa Barrueto et al. Translational Oncology
- TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer
- (2020) Timothy John Looney et al. Frontiers in Immunology
- Association of Tumor Microenvironment T-Cell Repertoire and Mutational Load With Clinical Outcome After Sequential Checkpoint Blockade in Melanoma
- (2019) Erik Yusko et al. Cancer Immunology Research
- Using T Cell Receptor Repertoires to Understand the Principles of Adaptive Immune Recognition
- (2019) Philip Bradley et al. Annual Review of Immunology
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
- (2019) Luca Mazzarella et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
- (2019) Yilun Wu et al. Frontiers in Immunology
- The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients
- (2019) Arjun Khunger et al. OncoImmunology
- Characterization of Distinct T Cell Receptor Repertoires in Tumor and Distant Non-tumor Tissues from Lung Cancer Patients
- (2019) Xiang Wang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Compartmental analysis of T cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
- (2019) Jiajia Zhang et al. CLINICAL CANCER RESEARCH
- Immune checkpoint inhibitors: a promising anticancer therapy
- (2019) Sima Singh et al. DRUG DISCOVERY TODAY
- TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
- (2019) Jiefei Han et al. Cancer Immunology Research
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
- (2018) Ludmila Danilova et al. Cancer Immunology Research
- Immune Repertoire Sequencing Using Molecular Identifiers Enables Accurate Clonality Discovery and Clone Size Quantification
- (2018) Ke-Yue Ma et al. Frontiers in Immunology
- Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer
- (2018) Valsamo Anagnostou et al. CANCER RESEARCH
- Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
- (2018) Sabrina A. Hogan et al. Cancer Immunology Research
- Quantifiable predictive features define epitope-specific T cell receptor repertoires
- (2017) Pradyot Dash et al. NATURE
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Identifying specificity groups in the T cell receptor repertoire
- (2017) Jacob Glanville et al. NATURE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PDL1 blockade
- (2017) Jie Bai et al. Oncotarget
- Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
- (2017) Alexandra Snyder et al. PLOS MEDICINE
- ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis
- (2017) John-William Sidhom et al. Cancer Immunology Research
- Quantitative Characterization of the T Cell Receptor Repertoire of Naïve and Memory Subsets Using an Integrated Experimental and Computational Pipeline Which Is Robust, Economical, and Versatile
- (2017) Theres Oakes et al. Frontiers in Immunology
- RTCR: a pipeline for complete and accurate recovery of T cell repertoires from high throughput sequencing data
- (2016) Bram Gerritsen et al. BIOINFORMATICS
- TRIg: a robust alignment pipeline for non-regular T-cell receptor and immunoglobulin sequences
- (2016) Sheng-Jou Hung et al. BMC BIOINFORMATICS
- The role of neoantigens in response to immune checkpoint blockade
- (2016) Nadeem Riaz et al. INTERNATIONAL IMMUNOLOGY
- How many TCR clonotypes does a body maintain?
- (2016) Grant Lythe et al. JOURNAL OF THEORETICAL BIOLOGY
- Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients
- (2016) S Mimmi et al. LEUKEMIA
- Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire
- (2016) Jennifer S. Sims et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
- (2016) Sumit K. Subudhi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation
- (2016) Giuseppe V. Masucci et al. Journal for ImmunoTherapy of Cancer
- IMSEQ—a fast and error aware approach to immunogenetic sequence analysis
- (2015) Leon Kuchenbecker et al. BIOINFORMATICS
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- T-cell receptor profiling in cancer
- (2015) Ilan Kirsch et al. Molecular Oncology
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Bioinformatic and Statistical Analysis of Adaptive Immune Repertoires
- (2015) Victor Greiff et al. TRENDS IN IMMUNOLOGY
- VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
- (2015) Mikhail Shugay et al. PLoS Computational Biology
- A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+T cell receptor repertoire clonality
- (2015) Wei Zhu et al. OncoImmunology
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing
- (2014) Mathieu Giraud et al. BMC GENOMICS
- Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice
- (2014) Victor Greiff et al. BMC IMMUNOLOGY
- Deconstructing the Peptide-MHC Specificity of T Cell Recognition
- (2014) Michael E. Birnbaum et al. CELL
- The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
- (2014) A. Ribas et al. CLINICAL CANCER RESEARCH
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- Nivolumab for the treatment of cancer
- (2014) Anasuya Gunturi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
- (2014) E. Cha et al. Science Translational Medicine
- Quantification of HTLV-1 Clonality and TCR Diversity
- (2014) Daniel J. Laydon et al. PLoS Computational Biology
- MiTCR: software for T-cell receptor sequencing data analysis
- (2013) Dmitriy A Bolotin et al. NATURE METHODS
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations
- (2013) P. G. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using synthetic templates to design an unbiased multiplex PCR assay
- (2013) Christopher S. Carlson et al. Nature Communications
- Sequence analysis of T-cell repertoires in health and disease
- (2013) Daniel J Woodsworth et al. Genome Medicine
- Next generation sequencing for TCR repertoire profiling: Platform-specific features and correction algorithms
- (2012) Dmitry A. Bolotin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High Frequency of Herpesvirus-Specific Clonotypes in the Human T Cell Repertoire Can Remain Stable over Decades with Minimal Turnover
- (2012) M. A. Neller et al. JOURNAL OF VIROLOGY
- Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells
- (2012) Jennifer N. Lynch et al. MOLECULAR IMMUNOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes
- (2011) R. L. Warren et al. GENOME RESEARCH
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Counting absolute numbers of molecules using unique molecular identifiers
- (2011) Teemu Kivioja et al. NATURE METHODS
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- On the Composition of the Preimmune Repertoire of T Cells Specific for Peptide–Major Histocompatibility Complex Ligands
- (2010) Marc K. Jenkins et al. Annual Review of Immunology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive assessment of T-cell receptor -chain diversity in T cells
- (2009) H. S. Robins et al. BLOOD
- Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing
- (2009) J. D. Freeman et al. GENOME RESEARCH
- Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing
- (2009) S. D. Boyd et al. Science Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started